MAGE-A inhibits apoptosis in proliferating myeloma cells through repression of Bax and maintenance of survivin.

Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
Tricia NardielloHearn Jay Cho

Abstract

The type I Melanoma Antigen GEnes (MAGEs) are commonly expressed in cancers, fueling speculation that they may be therapeutic targets with oncogenic potential. They form complexes with RING domain proteins that have E3 ubiquitin ligase activity and promote p53 degradation. MAGE-A3 was detected in tumor specimens from patients with multiple myeloma and its expression correlated with higher frequencies of Ki-67(+) malignant cells. In this report, we examine the mechanistic role of MAGE-A in promoting survival of proliferating multiple myeloma cells. The impact of MAGE-A3 expression on survival and proliferation in vivo was examined by immunohistochemical analysis in an independent set of tumor specimens segregated into two groups: newly diagnosed, untreated patients and patients who had relapsed after chemotherapy. The mechanisms of MAGE-A3 activity were investigated in vitro by silencing its expression by short hairpin RNA interference in myeloma cell lines and primary cells and assessing the resultant effects on proliferation and apoptosis. MAGE-A3 was detected in a significantly higher percentage of relapsed patients compared with newly diagnosed, establishing a novel correlation with progression of disease. Silencing of MAGE-...Continue Reading

References

Aug 5, 2000·Cancer·S A ElyD M Knowles
May 15, 2001·International Journal of Cancer. Journal International Du Cancer·A A JungbluthL J Old
Nov 21, 2001·The Journal of Biological Chemistry·William H HoffmanMaureen Murphy
Nov 26, 2002·Immunological Reviews·Matthew J ScanlanYao-Tseng Chen
Jul 13, 2004·Mayo Clinic Proceedings·Shaji K KumarPhilip R Greipp
Jul 22, 2005·Nature Reviews. Cancer·Andrew J G SimpsonLloyd J Old
Jul 19, 2006·Proceedings of the National Academy of Sciences of the United States of America·Martin MonteClaudio Schneider
Mar 12, 2008·Blood·Robert A Kyle, S Vincent Rajkumar
Aug 14, 2008·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Alain C MitaFrancis J Giles
Dec 18, 2009·Haematologica·Djordje AtanackovicNicolaus Kröger
Sep 25, 2010·Molecular Cell·Jennifer M DoylePatrick Ryan Potts

❮ Previous
Next ❯

Citations

Apr 5, 2011·Cancer Immunology, Immunotherapy : CII·Larry D AndersonStanley R Riddell
Mar 22, 2016·Human Pathology·Naohiro MakiseMasashi Fukayama
Nov 7, 2015·Biochimica Et Biophysica Acta·Sander Kelderman, Pia Kvistborg
Dec 3, 2014·Experimental and Molecular Pathology·Xin XuJin Zhu
Oct 13, 2015·British Journal of Haematology·Nesrine LajmiDjordje Atanackovic
May 29, 2012·Cancer Letters·David W Meek, Lynnette Marcar
Jun 6, 2012·Cancer Letters·María Fátima LadelfaMartín Monte
Sep 8, 2015·Current Opinion in Cell Biology·Jenny L Weon, Patrick Ryan Potts
Oct 26, 2012·The Journal of Investigative Dermatology·Neehar BhatiaB Jack Longley
Sep 10, 2014·International Journal of Cancer. Journal International Du Cancer·Lei WangMichael Schmitt
Nov 6, 2012·International Journal of Cancer. Journal International Du Cancer·Chantal MengusTvrtko Hudolin
Mar 22, 2016·Seminars in Immunology·Reno DebetsGeorge Coukos
Jun 24, 2015·Immunotherapy·Ali Esfandiary, Soudeh Ghafouri-Fard
Jun 20, 2015·Journal of Translational Medicine·Sara YousefDjordje Atanackovic
Feb 5, 2013·Journal of Cranio-maxillo-facial Surgery : Official Publication of the European Association for Cranio-Maxillo-Facial Surgery·Stefan HartmannUrs D A Müller-Richter
Oct 17, 2017·Clinical Oral Investigations·Stefan HartmannUrs D A Müller-Richter
Aug 6, 2011·Nature Medicine·Megan Scudellari
Jul 10, 2019·Journal of Experimental & Clinical Cancer Research : CR·Biswajit Das, Shantibhusan Senapati
Oct 2, 2012·Oncology Reports·Jiaqin YanXudong Zhang
Jul 15, 2015·Oncotarget·Morten F GjerstorffHenrik J Ditzel
Oct 24, 2013·Diseases of the Esophagus : Official Journal of the International Society for Diseases of the Esophagus·H OyaY Kodera

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cancer Genomics (Keystone)

Cancer genomics approaches employ high-throughput technologies to identify the complete catalog of somatic alterations that characterize the genome, transcriptome and epigenome of cohorts of tumor samples. Discover the latest research using such technologies in this feed.

Apoptosis in Cancer

Apoptosis is an important mechanism in cancer. By evading apoptosis, tumors can continue to grow without regulation and metastasize systemically. Many therapies are evaluating the use of pro-apoptotic activation to eliminate cancer growth. Here is the latest research on apoptosis in cancer.

Apoptosis

Apoptosis is a specific process that leads to programmed cell death through the activation of an evolutionary conserved intracellular pathway leading to pathognomic cellular changes distinct from cellular necrosis